Links to articles in the current and previous 2 issues of this bulletin are displayed below.
To receive email notifications about new issues of this bulletin, please email: richard.fallis@healthcarelibrary.qub.ac.uk
Advancing autoimmune rheumatic disease treatment: CAR-T cell therapies
ASAS consensus definition of early axial spondyloarthritis
Bone and entheseal targets for growth factors in diffuse idiopathic skeletal hyperostosis
Definitions of rheumatoid arthritis flare and how they relate to patients’ perspectives
Efficacy and safety of treat-to-target strategy studies in rheumatic diseases
Genetic approaches to study rheumatic diseases and its implication in clinical practice
Impact of climate change on rheumatic diseases
Informing digital programs for lupus self-management education
Investigating the disparities among drug categories in drug-induced dermatomyositis
Lay health worker interventions in rheumatology
Machine learning in the prediction of treatment response in rheumatoid arthritis
Minimally invasive interventional procedures for osteoarthritis and inflammatory arthritis
Multiplicative impact of adverse social determinants of health on outcomes in lupus nephritis
Role of intravenous immunoglobulins in systemic sclerosis (SSc)
Vascular disease persistence in giant cell arteritis: are stromal cells neglected?
Annals of the Rheumatic Diseases (Aug-Sep); Arthritis and Rheumatology (Aug-Sep); Arthritis Care and Research (Aug-Sep); Journal of Climate Change and Health, The (Sep-Oct); Seminars in Arthritis and Rheumatism (Aug-Oct)
Are the effects of resistance exercise on pain and function in knee and hip osteoarthritis dependent on exercise volume, duration, and adherence 10.1002/acr.25313
Choosing to end African American health disparities in patients with systemic lupus erythematosus 10.1002/art.42797
Comparative risk of gout flares when initiating or escalating various urate-lowering therapy 10.1002/acr.25309
Essential fatty acids and osteoarthritis 10.1002/acr.25302
EULAR recommendations: 2023 updates
Global burden of early-onset osteoarthritis, 1990–2019: results from the Global Burden of Disease Study 2019 10.1136/ard-2023-225324
Imaging of rheumatic diseases affecting the lower limb 10.1016/j.rdc.2024.03.010
Immune response to post-translationally modified proteins in rheumatoid arthritis: what makes it special? 10.1136/ard-2023-224103
Inflammatory arthritis in systemic sclerosis: its epidemiology, associations, and morbidity 10.1002/acr.25311
Newer immunosuppressants for rheumatologic disease 10.1016/j.rdc.2024.03.006
Non‐surgical interventions for treating osteoarthritis of the big toe joint 10.1002/14651858.CD007809.pub3
Prospects of disease-modifying osteoarthritis drugs 10.1016/j.rdc.2024.03.003
The role of psychology in pediatric rheumatic diseases 10.1016/j.rdc.2024.05.001
Standing on shoulders: interferon research from viral interference to lupus pathogenesis and treatment 10.1002/art.42849
What rheumatologists need to know about mRNA vaccines: current status and future of mRNA vaccines in autoimmune inflammatory rheumatic diseases 10.1136/ard-2024-225492
Annals of the Rheumatic Diseases (Jun-Jul); Arthritis and Rheumatology (Jun-Jul); Arthritis Care and Research (Jun-Jul); Cochrane Library (Jun); Rheumatic Disease Clinics of Northern America (Aug)
CD19 chimeric antigen receptor T cell treatment: unraveling the role of B cells in systemic lupus erythematosus 10.1002/art.42784
Difficult-to-treat psoriatic arthritis: a conceptual approach 10.1002/art.42780
Effectiveness of longstanding exercise therapy compared with usual care for people with rheumatoid arthritis and severe functional limitations: a randomised controlled trial 10.1136/ard-2023-224912
Effects of exercise-based interventions on inflammatory markers in patients with fibromyalgia: A systematic review and meta-analysis 10.1016/j.semarthrit.2024.152377
EPO promotes the progression of rheumatoid arthritis by inducing desialylation via increasing the expression of neuraminidase 10.1136/ard-2023-224852
Exposure to air pollutants and rheumatoid arthritis biomarkers: a scoping review 10.1016/j.semarthrit.2024.152365
Factors associated with diagnostic delay in axial spondyloarthritis: impact of clinical factors and social vulnerability 10.1002/acr.25264
Incidence of uveitis in patients with axial spondylarthritis treated with biologics or targeted synthetics: a systematic review and network meta-analysis 10.1002/art.42788
The management of cardiovascular risk in psoriatic disease: A bridge over troubled water 10.1016/j.semarthrit.2024.152389
Pathogenesis of gout: exploring more therapeutic target 10.1111/1756-185X.15147
Prognostic model to predict the incidence of radiographic knee osteoarthritis 10.1136/ard-2023-225090
Qualitative evaluation of connective tissue disease with cytomegalovirus infection: a meta-analysis of case reports 10.1016/j.semarthrit.2024.152396
Shift in perspective: autoimmunity protecting against rheumatoid arthritis 10.1136/ard-2023-225237
A stepwise approach to analyzing musculoskeletal imaging data with artificial intelligence 10.1002/acr.25260
Weight loss for patients with gout and concomitant obesity: a proof-of-concept randomized trial 10.1002/art.42790
Weight loss induced by antiobesity medications and all-cause mortality among patients with knee or hip osteoarthritis 10.1002/art.42754
Annals of the Rheumatic Diseases (Apr-May); Arthritis and Rheumatology (Apr-May); Arthritis Care and Research (Apr-May); BMJ, The (30th Apr); International Journal of Rheumatic Diseases (Apr); Seminars in Arthritis and Rheumatism (Apr)